![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Print Issue November 2017
Auditory Therapy, Ototoxicity and GLP Compliance Will the promising market for ear disorder treatments follow ophthalmology’s dramatic growth curve?
CILcare Inc
The numbers are daunting – 15% of the global population suffers from hearing loss, inclu...
Direct-to-Patient Solutions Assuring Patient Participation and Retention in Clinical Trials
QuickSTAT
The average cost of bringing a new drug to market is $2.6 billion, according to a 2014 rep...
Asia’s increasing levels of clinical trial industry competition are to your benefit
Biotechnology and pharmaceutical companies within the United States and Europe face an i...
Time for a Different Approach to Quality Systems in Biopharmaceutical Manufacturing
Lonza Group AG
Despite the wide array of information systems available for biopharmaceutical manufacturin...
New centre is tackling manufacturing challenge of cell therapy field
CCRM
Stem cell science has made huge progress since the early 1960s when Canadian researchers J...
Nativis’ platform aims to transform disease treatment on a global scale – “a symphony of cures”
Nativis Inc
In late 2015, I was approached by the board of Nativis, Inc.to take on the leadership of t...
Innovative oral dissolving CureFilm moves drug delivery platforms into the future
CURE Pharmaceutical
CURE Pharmaceutical has developed innovative drug delivery technology in CureFilm, an oral...
A New Approach To Pharmacovigilance
1.Quanticate has just completed an investment initiative to upgrade its pharmacovigilance ...
